Analyst picks & changes

Amgen Inc.

(AMGN)

Oppenheimer & Co. analyst Matthew Geller said AMGN underscored its determination to remain independent with the appointment last week

Read the full 225 word article

How to gain access

Continue reading with a
two-week free trial.